1. Repetitive acute intermittent hypoxia increases growth/neurotrophic factor expression in non-respiratory motor neurons
- Author
-
Gordon S. Mitchell, Irawan Satriotomo, A.T. Emery, Nicole L. Nichols, Erica A. Dale, and Jenny M Dahlberg
- Subjects
Male ,Vascular Endothelial Growth Factor A ,0301 basic medicine ,Tropomyosin receptor kinase B ,Biology ,Neuroprotection ,Article ,Rats, Sprague-Dawley ,Random Allocation ,03 medical and health sciences ,0302 clinical medicine ,Neurotrophic factors ,medicine ,Animals ,Receptor, trkB ,Phosphorylation ,Hypoxia ,Motor Neurons ,Lumbar Vertebrae ,Brain-Derived Neurotrophic Factor ,General Neuroscience ,Motor Cortex ,Intermittent hypoxia ,Motor neuron ,Hypoxia-Inducible Factor 1, alpha Subunit ,Immunohistochemistry ,Vascular endothelial growth factor A ,030104 developmental biology ,medicine.anatomical_structure ,Spinal Cord ,nervous system ,Cervical Vertebrae ,Primary motor cortex ,Neuroscience ,030217 neurology & neurosurgery ,Motor cortex - Abstract
Repetitive acute intermittent hypoxia (rAIH) increases growth/trophic factor expression in respiratory motor neurons, thereby eliciting spinal respiratory motor plasticity and/or neuroprotection. Here we demonstrate that rAIH effects are not unique to respiratory motor neurons, but are also expressed in non-respiratory, spinal alpha motor neurons and upper motor neurons of the motor cortex. In specific, we used immunohistochemistry and immunofluorescence to assess growth/trophic factor protein expression in spinal sections from rats exposed to AIH three times per week for 10 weeks (3 × wAIH). 3 × wAIH increased brain-derived neurotrophic factor (BDNF), its high-affinity receptor, tropomyosin receptor kinase B (TrkB), and phosphorylated TrkB (pTrkB) immunoreactivity in putative alpha motor neurons of spinal cervical 7 (C7) and lumbar 3 (L3) segments, as well as in upper motor neurons of the primary motor cortex (M1). 3 × wAIH also increased immunoreactivity of vascular endothelial growth factor A (VEGFA), the high-affinity VEGFA receptor (VEGFR-2) and an important VEGF gene regulator, hypoxia-inducible factor-1α (HIF-1α). Thus, rAIH effects on growth/trophic factors are characteristic of non-respiratory as well as respiratory motor neurons. rAIH may be a useful tool in the treatment of disorders causing paralysis, such as spinal injury and motor neuron disease, as a pretreatment to enhance motor neuron survival during disease, or as preconditioning for cell-transplant therapies.
- Published
- 2016
- Full Text
- View/download PDF